TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16621194

Group type: EXPERIMENTAL
Intervention: Pentavalent vaccine (G1, G2, G3, G4, and P1A)
Number of subjects: 1946

Group type: EXPERIMENTAL
Intervention: Monovalent P1A vaccine
Number of subjects: 1946

Group type: COMPARATOR
Intervention: Vaccine group
Number of subjects: 1946

Group type: EXPERIMENTAL
Intervention: Low-potency pentavalent vaccine
Number of subjects: 1946
Study: 12536263

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day + Pindolol 2.5 mg three times a day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Paroxetine 20 mg/day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Pindolol 2.5 mg three times a day
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11236243

Group type: EXPERIMENTAL
Intervention: Granulocyte colony stimulating factor (G-CSF)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Carcinoembryonic antigen (CEA)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cytokeratin fragment 19 (CYFRA 21-1)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CEA
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: CYFRA 21-1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combined use of G-CSF and CEA
Number of subjects: 34
Study: 8628044

Group type: EXPERIMENTAL
Intervention: Health Maintenance Organization (HMO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fee-for-Service Medicaid
Number of subjects: 0
Study: 1596703

Group type: EXPERIMENTAL
Intervention: Low dose alpha-interferon (5 x 10(5) iu, twice a week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6439100

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 734

Group type: EXPERIMENTAL
Intervention: Warfarin
Number of subjects: 734
Study: 30507032

Group type: EXPERIMENTAL
Intervention: Sonic-powered toothbrush
Number of subjects: 32

Group type: COMPARATOR
Intervention: Soft-bristle manual toothbrush
Number of subjects: 32
Study: 29505522

Group type: EXPERIMENTAL
Intervention: Low tidal volume (VT < 8 mL/kg) + pressure controlled ventilation (PCV)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Low tidal volume (VT < 8 mL/kg) + volume-controlled ventilation (VCV)
Number of subjects: 180

Group type: COMPARATOR
Intervention: High tidal volume (VT ≥ 8 mL/kg) + pressure controlled ventilation (PCV)
Number of subjects: 180

Group type: COMPARATOR
Intervention: High tidal volume (VT ≥ 8 mL/kg) + volume-controlled ventilation (VCV)
Number of subjects: 180
Study: 26811112

Group type: EXPERIMENTAL
Intervention: Midurethral sling placement with retropubic approach
Number of subjects: 2123

Group type: EXPERIMENTAL
Intervention: Previous bariatric surgery
Number of subjects: 2123

Group type: EXPERIMENTAL
Intervention: Preoperative hemoglobin <13 g/dL
Number of subjects: 2123

Group type: EXPERIMENTAL
Intervention: Premenopausal status
Number of subjects: 2123

Group type: EXPERIMENTAL
Intervention: Preoperative estrogen therapy among postmenopausal patients with mesh exposure
Number of subjects: 2123
Study: 25217457

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 5054

Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents (ZES-R)
Number of subjects: 5054
Study: 22669792

Group type: EXPERIMENTAL
Intervention: Videogame players
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonvideogame players
Number of subjects: 0
Study: 21069899

Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 2.0 ng/ml (RF₂(.)₀)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 2.5 ng/ml (RF₂(.)₅)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remifentanil at an effect-site concentration of 1.5 ng/ml (RF₁(.)₅)
Number of subjects: 90
Study: 17707537

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 224

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy (CMF)
Number of subjects: 224

Group type: EXPERIMENTAL
Intervention: Low expression of the BRCA1/BRCA2/Rad51 complex
Number of subjects: 224
Study: 12676056

Group type: EXPERIMENTAL
Intervention: Patients with mild Parkinson's disease
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Healthy elderly with mild‐to‐moderate hippocampal atrophy
Number of subjects: 3

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 3
Study: 10877311

Group type: EXPERIMENTAL
Intervention: ZDV+ddC treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: ZDV alone
Number of subjects: 0
Study: 8623182

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Azathioprine-Prednisone (Aza-Pred)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Aza-Pred
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: CsA
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: CsA and Aza-Pred
Number of subjects: 127
Study: 1417189

Group type: EXPERIMENTAL
Intervention: Topically applied recombinant basic fibroblast growth factor (bFGF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6426073

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 2 mg inhaled from a pressurised metered dose inhaler
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 10 mg inhaled from a pressurised metered dose inhaler
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 20 mg inhaled from a pressurised metered dose inhaler
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate 20 mg inhaled from a Spincap
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30990550

Group type: EXPERIMENTAL
Intervention: Doxepin mouthwash (25 mg/5 mL water)
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Diphenhydramine-lidocaine-antacid mouthwash
Number of subjects: 275

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Doxepin mouthwash
Number of subjects: 275
Study: 28827196

Group type: EXPERIMENTAL
Intervention: Group 1 (4-hour theoretical training followed by simulations)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Group 2 (4-hour training first followed by simulations)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group 1
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group 2
Number of subjects: 20
Study: 25811308

Group type: EXPERIMENTAL
Intervention: Sport Supplements (SS)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Fast Food (FF)
Number of subjects: 11
Study: 22899427

Group type: EXPERIMENTAL
Intervention: Acquiring New Skills While Enhancing Remaining Strengths (ANSWERS) intervention; 6-curriculum guided sessions with an intervention specialist.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group; no specific intervention details provided.
Number of subjects: 0
Study: 21030675

Group type: EXPERIMENTAL
Intervention: Indomethacin (oral 2 × 100 mg Confortid daily for 7 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19429669

Group type: EXPERIMENTAL
Intervention: remifentanil 1 microg kg(‐1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: saline (control)
Number of subjects: 42
Study: 17303494

Group type: EXPERIMENTAL
Intervention: Misoprostol 6-8 hours after mifepristone treatment
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Misoprostol 24 hours after mifepristone treatment
Number of subjects: 1080
Study: 19238647

Group type: EXPERIMENTAL
Intervention: 10% lidocaine spray plus 2% lidocaine jelly lubrication
Number of subjects: 60

Group type: COMPARATOR
Intervention: 2% lidocaine jelly lubrication alone
Number of subjects: 60
Study: 11081321

Group type: EXPERIMENTAL
Intervention: Hypertensive group
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study: 9011481

Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b (10 MU administered subcutaneously daily until normalization of serum transaminase concentrations)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-dose interferon-alpha2b
Number of subjects: 24
Study: 1291635

Group type: EXPERIMENTAL
Intervention: Magnetostrictive scaler
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Piezoelectric scaler
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Air turbine scaler
Number of subjects: 40
Study: 6479057

Group type: EXPERIMENTAL
Intervention: Intensive training programme
Number of subjects: 238

Group type: COMPARATOR
Intervention: Standard training programme
Number of subjects: 238

Group type: COMPARATOR
Intervention: 14 months post-training assessment
Number of subjects: 238
Study: 31434028

Group type: EXPERIMENTAL
Intervention: Non-tobacco flavored e-cigarettes (fruit, menthol)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Menthol flavored e-cigarettes
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nicotine-containing e-cigarettes (6 mg/mL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Nicotine-free e-cigarettes
Number of subjects: 100
Study: 29150312

Group type: EXPERIMENTAL
Intervention: Childcare intervention alone (CC)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Childcare intervention with parental component (CC+HOME)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Typical curriculum comparison group (COM)
Number of subjects: 18
Study: 27019413

Group type: EXPERIMENTAL
Intervention: Surgical navigation
Number of subjects: 10

Group type: COMPARATOR
Intervention: No surgical navigation
Number of subjects: 10
Study: 24584988

Group type: EXPERIMENTAL
Intervention: ACT Plus (N=74) - provided evidence-based interventions (psychoeducation, family interventions, individual placement and support, cognitive behavioral therapy)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Standard ACT (N=85) - provided standard assertive community treatment
Number of subjects: 159
Study: 22910929

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (CR; n = 26)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hypofractionated tomotherapy (TT; n = 34)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both treatment arms (CR and TT)
Number of subjects: 60
Study: 20417565

Group type: EXPERIMENTAL
Intervention: Myoconjunctival PMMA implant
Number of subjects: 150

Group type: COMPARATOR
Intervention: Traditional PMMA implant
Number of subjects: 150

Group type: COMPARATOR
Intervention: Porous polyethylene implant
Number of subjects: 150
Study: 18826868

Group type: EXPERIMENTAL
Intervention: Trileptal oral suspension (300 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Film-coated tablet (300 mg)
Number of subjects: 19
Study: 15915007

Group type: EXPERIMENTAL
Intervention: formoterol pMDI (12-microg dose)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: formoterol DPI (Aerolizer, 12-microg dose)
Number of subjects: 49

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 49
Study: 12843212

Group type: EXPERIMENTAL
Intervention: (99m)Tc-TRODAT-1 SPECT
Number of subjects: 20

Group type: COMPARATOR
Intervention: (18)F-FDOPA PET
Number of subjects: 20
Study: 10382128

Group type: EXPERIMENTAL
Intervention: Oral ferrous sulfate and a 2-week course of bismuth subcitrate, amoxicillin, and metronidazole (Group A)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Placebo for iron and a 2-week course of triple therapy (Group B)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Oral ferrous sulfate and a 2-week course of placebo (Group C)
Number of subjects: 43
Study: 9715289

Group type: EXPERIMENTAL
Intervention: High flow oxygen (O2) inhalation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sublingual isosorbide dinitrate (ISDN)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intravenous aminophylline (AMN)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sublingual nifedipine (NIF)
Number of subjects: 32
Study: 2057244

Group type: EXPERIMENTAL
Intervention: EXOSURF (5 mL/kg intratracheally)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control (air 5 mL/kg intratracheally)
Number of subjects: 178
Study: 30849345

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept monotherapy (IAI) 2 mg every 4 weeks until week 12, then every 8 weeks if no rescue needed; every 4 weeks plus sham/active PDT if rescue criteria met.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intravitreal aflibercept plus rescue photodynamic therapy (IAI + rPDT).
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept monotherapy (IAI)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intravitreal aflibercept plus rescue photodynamic therapy (IAI + rPDT)
Number of subjects: 54
Study: 28127507

Group type: EXPERIMENTAL
Intervention: Dalfampridine treatment for 12–14 days
Number of subjects: 34
Study: 26011140

Group type: EXPERIMENTAL
Intervention: Alfuzosin SR 5 mg twice daily in addition to standard of care management
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard of care management (daily oral hydration and diclofenac 75 mg IM on demand)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group only
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Alfuzosin therapy
Number of subjects: 54
Study: 23800222

Group type: EXPERIMENTAL
Intervention: Abstinent drinking goal
Number of subjects: 680

Group type: COMPARATOR
Intervention: Nonabstinent drinking goal
Number of subjects: 680
Study: 21826719

Group type: EXPERIMENTAL
Intervention: Abdominal hypopressive technique (AHT)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combination of AHT + PFM
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: AHT + PFM
Number of subjects: 34
Study: 20197168

Group type: EXPERIMENTAL
Intervention: Interceptive orthodontics (IO)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 170
Study: 18254272

Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both on-pump and off-pump
Number of subjects: 40

Group type: COMPARATOR
Intervention: On-pump vs Off-pump
Number of subjects: 40
Study: 16133853

Group type: EXPERIMENTAL
Intervention: ICE guided cardioversion
Number of subjects: 400

Group type: COMPARATOR
Intervention: Conventional cardioversion strategy
Number of subjects: 400
Study: 12216152

Group type: EXPERIMENTAL
Intervention: CAM walker
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cast
Number of subjects: 50
Study: 9564796

Group type: EXPERIMENTAL
Intervention: Anti-mite shampoo
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo shampoo
Number of subjects: 85

Group type: COMPARATOR
Intervention: Parental control
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Uncarpeted floors and mattress encasements
Number of subjects: 85
Study: 7649343

Group type: EXPERIMENTAL
Intervention: Calcium intake in girls
Number of subjects: 35072

Group type: EXPERIMENTAL
Intervention: Calcium intake in boys
Number of subjects: 35072

Group type: EXPERIMENTAL
Intervention: Food-frequency questionnaire
Number of subjects: 35072
Study: 2764269

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch solution (HD-HES group, n = 15, ratio of replacement 1:1)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Ringer's lactate (HD-RL group, n = 15, ratio 2.5:1)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No hemodilution (Control group, n = 15)
Number of subjects: 45
Study: 1036604

Group type: EXPERIMENTAL
Intervention: Iodoxamic acid (Endomirabil)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Other intravenous contrast media
Number of subjects: 86
Study: 31125470

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Midazolam (0.08 mg/kg)
Number of subjects: 90
Study: 27913576

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 333

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study: 26382732

Group type: EXPERIMENTAL
Intervention: Vitamin D status (serum 25-hydroxyvitamin D)
Number of subjects: 782
Study: 23449533

Group type: EXPERIMENTAL
Intervention: Steroid-free (SF) immunosuppression
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Steroid-based (SB) immunosuppression
Number of subjects: 130

Group type: COMPARATOR
Intervention: Both SF and SB groups
Number of subjects: 130

Group type: COMPARATOR
Intervention: Presence of de novo antibodies
Number of subjects: 130
Study: 21314651

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including a 6-hour training course and provision of technical aids (hip protectors, sensor mats)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Multifactorial intervention
Number of subjects: 333

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 333
Study: 19879495

Group type: EXPERIMENTAL
Intervention: Tailored messages for monitors
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Tailored messages for blunters
Number of subjects: 531

Group type: COMPARATOR
Intervention: Mismatched messages
Number of subjects: 531
Study: 16806710

Group type: EXPERIMENTAL
Intervention: Active laser treatment (300 mW, 830 nm)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham laser treatment (placebo)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Active laser treatment
Number of subjects: 90
Study: 12800795

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery followed by immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cytoreductive surgery
Number of subjects: 0
Study: 10701280

Group type: EXPERIMENTAL
Intervention: Professional-patient partnership model of discharge planning
Number of subjects: 158

Group type: COMPARATOR
Intervention: Usual discharge planning
Number of subjects: 158
Study: 9199862

Group type: EXPERIMENTAL
Intervention: Enhanced service
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual service
Number of subjects: 111
Study: 8468720

Group type: EXPERIMENTAL
Intervention: High-dose interleukin-2 plus lymphokine-activated killer (LAK) cells
Number of subjects: 181

Group type: COMPARATOR
Intervention: High-dose interleukin-2 alone
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: High-dose interleukin-2 plus LAK cells
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: High-dose interleukin-2 plus LAK cells (melanoma subgroup)
Number of subjects: 181

Group type: COMPARATOR
Intervention: High-dose interleukin-2 alone (melanoma subgroup)
Number of subjects: 181
Study: 2419524

Group type: EXPERIMENTAL
Intervention: PVB (cisplatin, vinblastine, and bleomycin)
Number of subjects: 180

Group type: COMPARATOR
Intervention: PVB plus doxorubicin
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Maintenance vinblastine
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: PVB
Number of subjects: 180
Study: 29529160

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 1609

Group type: COMPARATOR
Intervention: Corn-soy blends (CSB)
Number of subjects: 1609
Study: 26840358

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Magnesium
Number of subjects: 120

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 120
Study: 24886119

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention (childcare center intervention, family intervention, community intervention)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 357

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 357
Study: 23030580

Group type: EXPERIMENTAL
Intervention: Low health literacy
Number of subjects: 703

Group type: COMPARATOR
Intervention: Adequate health literacy
Number of subjects: 703
Study: 20033227

Group type: EXPERIMENTAL
Intervention: Gastrojejunostomy (GJJ)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Stent placement
Number of subjects: 39
Study: 18312323

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 140

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 140
Study: 15688235

Group type: EXPERIMENTAL
Intervention: Polidocanol (5 mg/ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lidocaine hydro‐chloride (5 mg/ml) + Adrenaline (5 microg/ml)
Number of subjects: 20
Study: 12231524

Group type: EXPERIMENTAL
Intervention: N-(4-Hydroxyphenyl)retinamide and tamoxifen
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10201419

Group type: EXPERIMENTAL
Intervention: National Adult Reading Test (NART)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cambridge Contextual Reading Test (CCRT)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Spot the Word Test (STW)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Demographic variables added to NART
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Demographic variables added to CCRT
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Demographic variables added to STW
Number of subjects: 25
Study: 7784025

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 7.5 mg
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate depot 3.75 mg
Number of subjects: 309

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (both dosages)
Number of subjects: 309
Study: 2327885

Group type: EXPERIMENTAL
Intervention: Hospital-supervised exercise
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination of hospital-supervised bicycling with home walking
Number of subjects: 52

Group type: COMPARATOR
Intervention: Home exercise with no specific guidance
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Home walking and hospital bicycling
Number of subjects: 52

Group type: COMPARATOR
Intervention: Completely unsupervised exercise at home
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Different exercise programs
Number of subjects: 52
Study: 6159077

Group type: EXPERIMENTAL
Intervention: vinblastine-bleomycin
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: doxorubicin-DDP
Number of subjects: 42
Study: 31948292

Group type: EXPERIMENTAL
Intervention: Endovascular revascularization
Number of subjects: 7746
Study: 30273493

Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation (2 × 200 mg/day for 8 weeks)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 29461622

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 225